GNRH1 and endometriosis: In randomized controlled trials (RCTs), GnRH agonists have been shown to be effective in reducing endometriosis-related pain [214], but they may also have adverse effects such as bone mineral density loss due to a hypoestrogenic state, requiring hormone “add-back” for long term use [213].